Loading...
HSChapter 30
U.S. exports of extracts of glands or other organs or secretions (HS 300120) totaled $5.5M in July 2026.
Extracts of Glands or Other Organs or Secretions imports of $2.7M in July 2026 ran 107% above the year-to-date monthly average of $1.3M.
Last updated: July 2026 dataGlandular and organ extracts — including those derived from pituitary, adrenal, thyroid, and other endocrine tissues — serve as raw materials for pharmaceutical manufacturing, diagnostic reagents, and research applications, and their import is subject to FDA review as biological source materials. All imports under the single 10-digit line 3001200000 may also require USDA APHIS review if derived from animal species subject to disease-related import restrictions. Spain and Japan are the leading suppliers to the US market, with Denmark also a significant source, reflecting strong veterinary and pharmaceutical processing industries in those countries. Admissibility can be complex; importers are advised to consult a licensed customs broker and confirm applicable FDA and APHIS requirements before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
17 shipments/mo
FDA reviews these materials as biological source substances when intended for pharmaceutical or diagnostic use, while USDA APHIS may impose additional restrictions based on the species of origin and the disease status of the exporting country. Importers should verify both agencies' requirements before arranging shipment, as clearance from one agency does not substitute for the other.
Species of origin does not change the HTS classification — all gland and organ extracts fall under 3001200000 regardless of whether they are bovine, porcine, or ovine — but it significantly affects admissibility. Extracts from species or countries subject to APHIS disease-related import restrictions (e.g., foot-and-mouth disease zones) may require additional permits or be refused entry entirely.
Subheading 2 of 2 in heading 3001
Subheading 300120 · $2.7M of $19.5M
Supplier Network
Get discovered by U.S. importers searching for HS 300120 — Extracts of Glands or Other Organs or Secretions. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share |
|---|---|---|---|---|
| 3001200000 | Extracts of Glands or Other Orgs or Secretions | $2.7M | 0.00% | 0.00% |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3001200000 | Extracts of Glands or Other Orgs or Secretions | $5.5M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$2.7MYoY · Pro
Exports
$5.5MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Exports · July 2026
destination
customs district
origin
entry
rate provision · imports
100.0% enters free of duty; the effective duty rate is 0.00%.